biovu

January 13, 2020

Vanderbilt-led team discovers new genetic disease and defines underlying mechanism

An international research team has discovered a new genetic syndrome caused by mutation of a single gene and named it CATIFA, an acronym for its core symptoms.

By Leigh MacMillan
November 19, 2019

Getting the goods on obesity

Obesity and two post-operative complications linked with it have associated genetic variants in common, suggesting that obesity may be the culprit.

By Paul Govern
July 8, 2019

Clinical study tests drug that may prevent cancer metastasis

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.

By Leigh MacMillan
April 24, 2019

Study merges big data and zebrafish biology to reveal mechanisms of human disease

In a series of studies that volleyed between large databases and research in zebrafish, Vanderbilt investigators have discovered a link between vascular biology and eye disease.

By Leigh MacMillan
January 31, 2019

Study explores genetic risk for suicide attempt

Using data from the UK Biobank and Vanderbilt’s BioVU, a new study in the journal Molecular Psychiatry finds that approximately 4 percent of suicide attempt risk is captured by genotype data.

By Paul Govern
October 15, 2018

Malin elected to National Academy of Medicine

Bradley Malin, PhD, professor of Biomedical Informatics, Biostatistics and Computer Science, is among 85 newly elected members of the National Academy of Medicine (NAM), the organization announced this week.

By Paul Govern
September 20, 2018

Fibromyalgia: More doctor visits mean fewer suicide attempts

Fibromyalgia patients who regularly visit their physicians are much less likely to attempt suicide than those who do not, according to a new Vanderbilt University Medical Center study published in Arthritis Care & Research.
By Craig Boerner
April 19, 2018

VUMC drug repurposing initiative gaining momentum

Drug repurposing involves establishing an additional approved indication for a drug already at market.
By Paul Govern
April 5, 2018

Nashville Biosciences created to leverage wealth of data

Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.
By Bill Snyder
March 22, 2018

Grant bolsters study of potential new therapy for C. diff infection

According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis.
By Paul Govern
March 15, 2018

Study spots undiagnosed genetic diseases in EHR

Patients diagnosed with heart failure, stroke, infertility and kidney failure could actually be suffering from rare and undiagnosed genetic diseases.
By Craig Boerner
February 26, 2018

Cannabis compound reduces seizures

Cannabidiol (CBD) oils reduced seizures in patients with difficult-to-treat epilepsy, Vanderbilt investigators have found.
By Leigh MacMillan
January 10, 2018

BioVU focus of Research Enterprise Forum Jan. 31

The School of Medicine will host a Research Enterprise Forum from 3 to 4 p.m. Wednesday, Jan. 31.
By VUMC News and Communications
1 2 3 4 5 6